2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Finley John David | CEO | 9,179,400 | Oct 8, 2025 |
| Jones Mitchell Lawrence | Chief Medical Officer | 7,665,800 | Oct 8, 2025 |
| Yuma Regional Medical Center | — | 1,814,375 | Aug 26, 2021 |
| Smith Sandford D | — | 219,916 | Jul 3, 2019 |
| Oldaker William Clyde | Director | 187,510 | Jul 3, 2019 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | Feb 13, 2026 | Jones Mitchell Lawrence | Chief Medical Officer | Sell | 47.5 | -1,989 | -13.04% | ✗ | $3.5K |
| Feb 11, 2026 | Feb 13, 2026 | Finley John David | CEO | Sell | 47.5 | -3,896 | -12.45% | ✗ | $6.8K |
| Feb 9, 2026 | Feb 11, 2026 | Jones Mitchell Lawrence | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 9, 2026 | Feb 11, 2026 | Finley John David | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 16, 2026 | Jan 21, 2026 | Williams Donald Allen | Director | Buy | 90.0 | +5,000 | 57.29% | ✗ | $8.4K |
| Jan 9, 2026 | Jan 13, 2026 | Williams Donald Allen | Director | Buy | 90.0 | +5,000 | 134.12% | ✗ | $9.4K |
| Oct 6, 2025 | Nov 6, 2025 | Williams Donald Allen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 6, 2025 | Nov 6, 2025 | Wei Binxian | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 6, 2025 | Nov 6, 2025 | Chuang Emil | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 6, 2025 | Oct 8, 2025 | Williams Donald Allen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 6, 2025 | Oct 8, 2025 | Wei Binxian | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 6, 2025 | Oct 8, 2025 | Jones Mitchell Lawrence | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 6, 2025 | Oct 8, 2025 | Finley John David | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 6, 2025 | Oct 8, 2025 | Chuang Emil | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 4, 2025 | Sep 5, 2025 | Williams Donald Allen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 4, 2025 | Sep 5, 2025 | Finley John David | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 4, 2025 | Sep 5, 2025 | Wei Binxian | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 4, 2025 | Sep 5, 2025 | Jones Mitchell Lawrence | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 4, 2025 | Sep 5, 2025 | Chuang Emil | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 18, 2025 | Jul 22, 2025 | Chuang Emil | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 17, 2025 | Chuang Emil | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 11, 2025 | Feb 13, 2025 | Jones Mitchell Lawrence | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 11, 2025 | Feb 13, 2025 | Finley John David | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 21, 2024 | Nov 22, 2024 | Williams Donald Allen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 21, 2024 | Nov 22, 2024 | Wei Binxian | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 11, 2024 | Jul 15, 2024 | Wei Binxian | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 11, 2024 | Jul 15, 2024 | Fischbein Margery B. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 11, 2024 | Jul 15, 2024 | Williams Donald Allen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2024 | Jun 12, 2024 | Wei Binxian | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2024 | Jun 12, 2024 | Williams Donald Allen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 28, 2024 | May 30, 2024 | Jones Mitchell Lawrence | Chief Medical Officer | Sell | 47.5 | -1,271 | -16.13% | ✗ | $6.1K |
| May 28, 2024 | May 30, 2024 | Finley John David | CEO | Sell | 47.5 | -2,033 | -5.48% | ✗ | $9.7K |
| May 28, 2024 | May 29, 2024 | Williams Donald Allen | Director | Buy | 90.0 | +1,000 | 50.00% | ✗ | $4.9K |
| May 24, 2024 | May 28, 2024 | Finley John David | CEO | Buy | 90.0 | +1,000 | 13.35% | ✗ | $4.8K |
| May 20, 2024 | May 22, 2024 | Finley John David | CEO | Neutral | 85.0 | +666 | 9.76% | ✗ | - |
| May 16, 2024 | Fischbein Margery B. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| May 6, 2024 | May 8, 2024 | Jones Mitchell Lawrence | CEO | Sell | 47.5 | -137 | -8.09% | ✗ | $1.2K |
| May 6, 2024 | May 8, 2024 | Finley John David | CEO | Sell | 50.0 | -128 | -0.94% | ✗ | $1.1K |
| Mar 11, 2024 | Mar 12, 2024 | Finley John David | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 9, 2024 | Feb 13, 2024 | Neal James R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 8, 2024 | Feb 13, 2024 | Csimma Cristina | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 8, 2024 | Feb 13, 2024 | Trenschel Robert J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 8, 2024 | Feb 13, 2024 | Diaz Stephanie | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 6, 2024 | Feb 8, 2024 | Jones Mitchell Lawrence | Chief Medical Officer | Sell | 27.5 | -2,153 | -21.94% | ✗ | $938.9 |
| Feb 6, 2024 | Feb 8, 2024 | Finley John David | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 6, 2024 | Feb 7, 2024 | Finley John David | CEO | Buy | 90.0 | +10,000 | 13.26% | ✗ | $4.7K |
| Jan 31, 2024 | Feb 1, 2024 | Finley John David | CEO | Buy | 90.0 | +10,000 | 15.28% | ✗ | $5.6K |
| Jan 31, 2024 | Feb 1, 2024 | Williams Donald Allen | Director | Buy | 90.0 | +10,000 | 50.00% | ✗ | $6.1K |
| Jan 3, 2024 | Jan 5, 2024 | Finley John David | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 11, 2023 | Dec 19, 2023 | Finley John David | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 21, 2023 | Nov 24, 2023 | Williams Donald Allen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 21, 2023 | Nov 24, 2023 | Jones Mitchell Lawrence | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 21, 2023 | Nov 24, 2023 | Trenschel Robert J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 21, 2023 | Nov 24, 2023 | Neal James R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 21, 2023 | Nov 24, 2023 | Diaz Stephanie | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 21, 2023 | Nov 24, 2023 | GRAY MARY ANN | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 20, 2023 | Nov 24, 2023 | Finley John David | CEO | Neutral | 90.0 | +10,000 | 20.59% | ✗ | - |
| Nov 21, 2023 | Nov 24, 2023 | Csimma Cristina | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 21, 2023 | Nov 24, 2023 | Wei Binxian | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 6, 2023 | Nov 8, 2023 | Jones Mitchell Lawrence | Chief Medical Officer | Sell | 27.5 | -1,630 | -35.78% | ✗ | $878.4 |
| Nov 6, 2023 | Nov 8, 2023 | Finley John David | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 3, 2023 | Oct 5, 2023 | Finley John David | CEO | Sell | 37.5 | -397 | -0.87% | ✗ | $218.4 |
| Sep 27, 2023 | Sep 29, 2023 | Williams Donald Allen | Director | Buy | 91.3 | +20,000 | 100.00% | ✗ | $10.8K |
| Sep 27, 2023 | Sep 29, 2023 | Finley John David | CEO | Buy | 90.0 | +15,000 | 51.42% | ✗ | $8.1K |
| Sep 14, 2023 | Sep 15, 2023 | Trenschel Robert J. | Director | Sell | 27.5 | -300 | -100.00% | ✗ | $192 |
| Sep 13, 2023 | Sep 14, 2023 | Finley John David | CEO | Buy | 90.0 | +15,000 | 105.85% | ✗ | $9.8K |
| Sep 13, 2023 | Jones Mitchell Lawrence | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 11, 2023 | Sep 13, 2023 | Finley John David | CEO | Sell | 27.5 | -1,792 | -11.23% | ✗ | $1.2K |
| Aug 6, 2023 | Aug 14, 2023 | Finley John David | CEO | Sell | 27.5 | -1,040 | -9.09% | ✗ | $728 |
| Jul 3, 2023 | Jul 6, 2023 | Finley John David | CEO | Sell | 27.5 | -389 | -4.65% | ✗ | $686.2 |
| Jun 12, 2023 | Jun 14, 2023 | Finley John David | CEO | Sell | 27.5 | -1,050 | -12.96% | ✗ | $1.6K |
| Jun 11, 2023 | Jun 13, 2023 | Trenschel Robert J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2023 | Jun 13, 2023 | Wei Binxian | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2023 | Jun 13, 2023 | Csimma Cristina | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2023 | Jun 13, 2023 | Diaz Stephanie | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2023 | Jun 13, 2023 | GRAY MARY ANN | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2023 | Jun 13, 2023 | Neal James R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2023 | Jun 13, 2023 | Williams Donald Allen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2023 | Jun 13, 2023 | Finley John David | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 3, 2023 | Apr 5, 2023 | McRae Robert Curtis | COO | Sell | 47.5 | -270 | -30.17% | ✗ | $540 |
| Apr 3, 2023 | Apr 5, 2023 | Finley John David | CEO | Sell | 47.5 | -435 | -8.60% | ✗ | $874.4 |
| Feb 15, 2023 | McRae Robert Curtis | COO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 6, 2023 | Feb 8, 2023 | Finley John David | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 3, 2023 | Jan 6, 2023 | Finley John David | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 1, 2022 | Sep 2, 2022 | Finley John David | CFO | Buy | 90.0 | +19,481 | 11.59% | ✗ | $2.8K |
| Aug 23, 2022 | Aug 25, 2022 | Finley John David | CFO | Buy | 82.5 | +7,350 | 4.57% | ✗ | $1.2K |
| Aug 16, 2022 | Aug 18, 2022 | Hallam Thomas | CEO | Buy | 91.3 | +40,000 | 227.38% | ✗ | $10K |
| Aug 16, 2022 | Aug 18, 2022 | Finley John David | CFO | Buy | 91.3 | +100,000 | 164.57% | ✗ | $25K |
| Apr 29, 2022 | May 2, 2022 | Finley John David | CFO | Neutral | 90.0 | +12,545 | 26.02% | ✗ | - |
| Mar 29, 2022 | Mar 31, 2022 | Dawson Michael John | Chief Medical Officer | Buy | 91.3 | +15,000 | 100.00% | ✗ | $17.1K |
| Mar 28, 2022 | Mar 29, 2022 | Hallam Thomas | CEO | Buy | 91.3 | +10,000 | 131.72% | ✗ | $11.8K |
| Mar 24, 2022 | Mar 25, 2022 | Finley John David | CFO | Buy | 90.0 | +7,500 | 18.42% | ✗ | $8.2K |
| Feb 17, 2022 | Feb 22, 2022 | Hallam Thomas | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 17, 2022 | Feb 22, 2022 | Finley John David | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 17, 2022 | Feb 22, 2022 | Dawson Michael John | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 18, 2021 | Feb 10, 2022 | Dawson Michael John | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 18, 2021 | Feb 10, 2022 | Finley John David | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 18, 2021 | Feb 10, 2022 | Hallam Thomas | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 18, 2021 | Feb 10, 2022 | Trenschel Robert J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 18, 2021 | Feb 10, 2022 | Williams Donald Allen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |